Koichi Nakatani
- Co-authors
- Kohei FujitaTadashi MioOsamu KanaiMisato OkamuraNaohiro UchidaYuki YamamotoSatoru SawaiMasayuki Hashimoto
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)Lung Cancer Treatments and Mutations (10 papers)Mycobacterium research and diagnosis (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaAnnals of OncologyEuropean Journal of Cancer
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Koichi Nakatani
37 papers receiving 428 citations
Peers
Comparison fields: 5 of 63
- Oncology 321
- Pulmonary and Respiratory Medicine 208
- Epidemiology 87
- Infectious Diseases 81
- Surgery 42
Countries citing papers authored by Koichi Nakatani
This map shows the geographic impact of Koichi Nakatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Nakatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Nakatani more than expected).
Fields of papers citing papers by Koichi Nakatani
This network shows the impact of papers produced by Koichi Nakatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Nakatani. The network helps show where Koichi Nakatani may publish in the future.
Co-authorship network of co-authors of Koichi Nakatani
This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Nakatani. A scholar is included among the top collaborators of Koichi Nakatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Nakatani. Koichi Nakatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 32 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 55 | |
| 11 | 7 | |
| 12 | 3 | |
| 13 | 73 | |
| 14 | 4 | |
| 15 | End-of-life care in Japanese patients with advanced COPD and chronic interstitial pneumonia: a cross-sectional study | 1 |
| 16 | 2 | |
| 17 | 17 | |
| 18 | 6 | |
| 19 | Therapeutic effect of ofloxacin on intractable pulmonary tuberculosis and ofloxacin resistance of tubercle bacilli isolated from the patients | 5 |
| 20 | [Therapeutic effect of ofloxacin on intractable pulmonary tuberculosis and ofloxacin resistance of tubercle bacilli isolated from the patients. Chest DIsease Cooperative Study Unit of National Sanatoriums in Kinki District]. | 6 |
About Koichi Nakatani
Koichi Nakatani is a scholar working on Microbiology, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 436 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (10 papers) and Mycobacterium research and diagnosis (8 papers). The work is most often cited by research in Oncology (321 citations), Pulmonary and Respiratory Medicine (208 citations) and Infectious Diseases (81 citations). Koichi Nakatani has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Kohei Fujita, Tadashi Mio, Osamu Kanai, Misato Okamura, Naohiro Uchida, Yuki Yamamoto, Satoru Sawai, Masayuki Hashimoto, Nobuaki Ikeda and Katsunori Saigenji. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.